PROSAP-A is a perioperative randomized, controlled trial with a 12-month follow-up period after total knee arthroplasty (TKA) or total hip arthroplasty (THA), aiming to investigate both acute and long-term postoperative effects of preoperative sleep-promotion. Participants with clinically significant insomnia symptoms will be randomized to a brief, hybrid version of cognitive behavioral therapy for insomnia (CBT-I) or sleep education therapy, administered over a 4-week period, prior to surgery. The primary objective is to evaluate effects of preoperative sleep-promotion on acute postoperative pain control. Secondary objectives include evaluation of postoperative sleep, recovery, mental health, cognitive function and alterations in blood biomarkers.
Although preoperative sleep disturbance is associated with poorer acute postoperative pain control, as well as development of chronic postsurgical pain, only very limited attempts have been made to target preoperative sleep to achieve improved postoperative outcomes. This study addresses two chronic pain populations, TKA and THA patients, that suffer severely due to both sleep disturbance and painful symptoms. Patients who meet eligibility criteria, including insomnia severity index score \>10 and confirmed DSM-V criteria for persistent insomnia disorder, will be randomized to a brief, hybrid version of CBT-I or sleep education therapy over a 4-week period, before surgery. The CBT-I will focus on the two components which have shown the highest efficacy for sleep improvement, sleep restriction therapy and stimulus control. The CBT-I treatment will be administered in self-guided digital format with addition of telehealth video-consultations with a psychologist one time per week. The sleep education therapy will also be provided in a hybrid format, including digital sessions and video-consultations with a research nurse. There will also be a booster session 1-2 weeks postoperative for both interventions. Participants will be carefully evaluated during on-site visits two times preoperative, pre- and post-intervention, and one time 6 months postoperative. During on-site visits, participants will complete multiple questionnaires (covering pain, pain catastrophizing, mental health, physical function, activity etc), undergo digital cognitive testing, quantitative sensory testing (QST, to determine pain detection thresholds to different stimuli, assess temporal summation, pain inhibitory capacity), provide blood samples, and initiate actigraphy (objective assessment of sleep continuity measures). In addition to the on-site visits, participants will complete questionnaires remotely 3 and 12 months after surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
100
Hybrid CBT-I (self-guided digital format focusing on sleep restriction therapy and stimulus control + telehealth video-consultations with psychologist)
Self-guided digital sleep education (sleep hygiene, sleep physiology, sleep disturbances etc) + telehealth video-consultations with research nurse
Department of Surgical Sciences, Uppsala University
Uppsala, Uppland, Sweden
RECRUITINGAcute postoperative pain intensity
Average pain intensity (NRS 0 - 10) over the past 24 h rated each morning, averaged over 7 days
Time frame: First 7 postoperative days
Pre- and acute postoperative change in sleep measures from baseline
insomnia severity index, Pittsburgh sleep quality index, actigraphic sleep continuity measures (sleep onset latency, total sleep time, wakefulness after sleep onset, sleep efficiency)
Time frame: Up to 2 weeks postoperative
Acute postoperative opioid consumption
Oral morphine mg equivalents (OMEQs)
Time frame: Postoperative day (POD) 1 and POD1-7
Recovery in the acute postoperative phase
Quality of recovery (QoR) 15 score
Time frame: First 7 postoperative days
Long-term postoperative sleep quality
insomnia severity index
Time frame: Up to 12 months postoperative
Postoperative objective sleep continuity
actigraphic sleep efficiency \[SE\]
Time frame: Up to 6 months postoperative
Pain intensity 6 months postoperative
Average pain intensity (NRS 0 - 10) over the past 24 h rated each morning, averaged over 7 days
Time frame: 6 months postoperative
Change in pain measures from baseline
BPI pain severity and pain interference score, QoR-15 pain score, WOMAC OA pain score
Time frame: Up to 12 months postoperative
Changes in quantitative sensory testing (QST) measures of pain
Pressure pain threshold, temporal summation, conditioned pain modulation, cold pressor test
Time frame: Up to 6 months postoperative
Change in cognitive function
Digital cognitive testing (Mindmore platform) incl. memory, attention and processing speed, executive functions
Time frame: Up to 6 months postoperative
Change in anxiety from baseline
Generalized anxiety disorder 7 (GAD-7) score
Time frame: Up to 6 months postoperative
Change in depression from baseline
Patient health questionnaire 9 (PHQ-9) score
Time frame: Up to 6 months postoperative
Change in quality of life
EuroQol 5 dimension 5 level (EQ-5D-5L), RAND-36
Time frame: Up to 6 months postoperative
Change in health-related function
EQ-5D-5L, RAND-36
Time frame: Up to 6 months postoperative
Change in osteoarthritis-related symptoms
WOMAC OA
Time frame: Up to 12 months postoperative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.